INFUSYSTEM HOLDINGS, INC Derivative Asset, Noncurrent
INFUSYSTEM HOLDINGS, INC (INFU) had Derivative Asset, Noncurrent of $807.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DerivativeAssetsNoncurrent · last filed 2026-08-04
- 2026-06-30: Derivative Asset, Noncurrent $807.00K.
- 2026-03-31: Derivative Asset, Noncurrent $766.00K.
- 2025-12-31: Derivative Asset, Noncurrent $748.00K.
- 2025-09-30: Derivative Asset, Noncurrent $850.00K.
| Period end | Derivative Asset, Noncurrent |
|---|---|
| 2026-06-30 | $807.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $766.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $748.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $850.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $949.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.15M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.48M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.11M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.71M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.72M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.44M 10-K · filed 2025-03-11 |
| 2023-09-30 | $2.17M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.91M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.68M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.97M 10-K · filed 2024-04-10 |
| 2021-12-31 | $355.00K 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |